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Pilomatrixoma; Trichomatricoma; Calcifying 
Epithelioma of Malherbe 
Note 
Benign skin tumor with follicular differentiation arising 
from hair cortex cells. 
Clinics and pathology 
Disease 
History: 
-1880: Malherbe and Chenantias described a benign 
neoplasm of the skin which they thought to be arising 
from sebaceous glands and called it as "I'epitheliome 
calcfie des glandes sebacees". Since then, it has been
termed as Calcifying Epithelioma of Malherbe. 
-1922: Dubreuilh and Cazenave gave the unique 
histopathologic description of this neoplasm consisting 
of basaloid and shadow/ghost cells. 
-1942: Turhan and Krainer determined that the origin 
of this neoplasm to be from hair matrix cells. 
-1961: Forbes and Helwig renamed the neoplasm as 
"Pilomatrixoma" to aptly describe its origin from hair 
follicle matrix cells and avoiding the word epithelioma 
which carried the connotation of malignancy. 
-1972: Harper reported the association of 
pilomatrixoma with myotonic dystrophy and suggested 
that this association probably represents a further 
pleiotropic effect of myotonic dystrophy gene. 
-1977: This name was changed to "Pilomatricoma" 
which was considered more etymologically correct.-
1962: Gorlin and his colleagues described Calcifying 
odontogenic cyst which has a distinct microscopic 
resemblance to Pilomatricoma and may represent an 
oral analog. 
-1990: Headington has used the name 
"trichomatricoma" to describe these neoplasms. 
Embryonic origin 
Pilomatricoma is thought to arise from hair matrix 
cells. 
Epidemiology 
Pilomatricoma accounts to 20% of all hair follicle 
related tumors in most series. Therefore, it can be 
considered as commonest hair follicle tumor. It 
predominantly affects the children and young adults 
with 40% of cases occurring before the age of 10 years 
and 60% of cases before the age of 20 years. However, 
it has also been reported in older adults. A bimodal age 
distribution of first and sixth decades has been repo t d 
by several authors. They exhibit a definite female 
preponderance with an M: F ratio of around 2:3 and re 
commonly encountered in whites.The most frequent 
anatomical location is in the head and neck region 
(>50%) followed by upper extremity, trunk and lower 
extremity. 
Clinics 
Pilomatricoma usually presents as a solitary, slow 
growing, asymptomatic, superficial/deeply seated, 
freely mobile, firm to rock hard mass ranging in size 
upto 0.5-5cm in diameter. The overlying skin can be 
normal or exhibit a bluish-red discoloration or even 
ulceration rarely. The diagnosis is usually suspected 
based on palpation of superficial rock hard mass and 
confirmed by histopathologic examination.  
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Pilomatricoma presenting as an erythematous swelling in the periorbital region. 
 
The tumor if stretched may show several facets and 
irregular angles, referred to as 'tent sign'. 
Multiple tumors and familial cases also occur. They are 
usually associated with Gardner's syndrome, Myotonic 
dystrophy, Steinert's disease, Rubinstein-Taybi 
syndrome, Turner's syndrome and sarcoidosis. 
Occasional variations like aggressive, symmetrically 
localized and giant lesions have also been reported. 
Radiology is of little diagnostic value. It is mainly used 
to differentiate pre-auricular tumors from parotid 
tumors and for evaluating large and aggressive tumors. 
Plain X rays reveal nonspecific calcification while 
ultrasound shows a well defined round hyperechogenic 
mass with post dense acoustic shadow. CT scan and 
MRI reveal a sharply demarcated, subcutaneous opaque 
lesion that does not enhance on injection of contrast 
material or small areas of signal dropout consistent 
with presence of calcifications. 
Cytology 
The aspirates usually reveal two types of cells i.e. 
anucleated shadow/ghost squamous cells and 
basaloid/basophilic squamous cells and nucleated 
squamous cells and areas of calcification. Generally, s 
the neoplasm ages, the aspirate will consist 
predominantly of shadow cells with few cells of other 
categories. 
Anucleated shadow cells: These are highly 
characteristic of pilomatricoma. They are present either 
as isolated cells or in small clusters. They are generally 
small, possess distinct cell borders with pink 
keratinized cytoplasm. A clear usually unstained area 
occupies the site of the nucleus but occasionally,  faint 
trace of the nuclei can be seen. 
Basaloid cells: These cells are arranged in tight clusters 
or in sheets. They were oval to polygonal with poorly 
defined cell borders and scanty cytoplasm, high 
nuclear-cytoplasmic ratio containing vesicular to 
hyperchromatic nuclei and occasional nucleoli. 
Additional findings: Chronic inflammatory cells, 
multinucleated giant cells, large fragments of calcific 
deposits. 
Pathology 
The neoplasm is usually well encapsulated containing 
irregularly shaped, lobulated islands of cells separated 
by fine, fibrovascular connective tissue stroma. The 
islands demonstrated two distinct cell populations i.e. 
comprising of basaloid cells located towards the 
periphery and the ghost/shadow cells occupying the 
central portion.  
The basaloid cells are darkly stained, round or 
elongated, with indistinct cell borders and minimal 
cytoplasm. They contain round to ovoid deeply 
basophilic nuclei with most showing prominent 
nucleoli.  
The ghost/shadow cells in the center of the islands 
have abundant, pale, eosinophilic cytoplasm with well
defined cell borders and central clear area. Most of 
them show only faint traces of nuclear material. A 
transition from basaloid to ghost cells is seen in most 
areas which may be abrupt or gradual. 
The shadow cells are formed due to keratinization of 
basaloid cells and tend to increase in number as the 
neoplasm ages. Secondary histopathogic features 
include hemorrhage, foci of calcification either in the 
form of fine basophilic granule or a large fragment of 
amorphous basophilic material, ossification, foreign 
body giant cells with inflammatory cells, whorls of
keratin, melanin pigmentation, myxoid change, 
necrosis etc. 
Treatment 
Surgical excision is the treatment of choice. 
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A: Photomicrograph depicting the encapsulated pilomatricoma composed of islands of cells with peripheral, dark basaloid cells; and pale 
central areas of shadow cells, along with areas of keratinisation. Inset: Magnified view of basaloid and ghost cells. 
B: Photomicrograph depicting the encapsulated pilomatricoma composed of islands of cells with peripheral, dark basaloid cells; and pale 
central areas of shadow cells, along with areas of keratinisation. Areas of cystic degeneration are also evident. 
C: Photomicrograph demonstrating peripheral darkly stained basaloid cells and central pale shadow cells. 
D: Showing areas of ghost cells, keratin material, giant cell reaction and inflammatory infiltrate. 
E: Showing whorls of keratin in the center of the islands. 
 
Evolution 
Most pilomatricomas increase slowly in size, some 
cease to grow to a small size while others grow upto a 
size of 15 cms. They can rupture spontaneously and 
discharge a chalky material. Hemorrhage within a 
pilomatricoma can lead to rapid enlargement. 
Malignant transformation into pilomatrical carcinoma 
has also been rarely described and has to be suspected 
if there is evidence of recent rapid growth, atypically 
large lesion, and ulceration, fixity to adjoining 
structures, infiltration or high mitotic activity. 
Prognosis 
They seldom recur, if the excision is complete. Local 
recurrence may develop due to incomplete excision. If 
multiple recurrences are noted, excision with margins 




Most cases of pilomatricoma occur sporadically 
without an apparent genetic predisposition.  
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However, few are associated with the following know 
genetic syndromes: 
- Gardner's syndrome 
- Turner's syndrome 
- Myotonic dystrophy 
- Steinert's disease 
- Rubenstein Taybi syndrome. 





Pilomatricomas usually contain mutation of CTNNB1, 
a gene encoding 92 kDa protein beta-catenin which is a 
multifunctional protein related to the adherens junction, 
signal transduction and is a key molecule of cell 
proliferation. It is central to epithelial architecure and 
regulates the polarity of cells and tissues. Beta-catenin 
stabilization may play a key role in epidermal signali g 
leading to hair development, and its aberrant activtion 
may be implicated in formation of hair tumors. Beta-
catenin gene mutations of the hair matrix cells stabilize 
beta-catenin proteins which accumulate in the 
cytoplasm and translocate to the nucleus. These beta-
catenin proteins in the nucleus in turn activate gene 
transcription via Wnt-TCF-Lef-1, resulting in abnormal 
matrical cell proliferation and formation of 
pilomatricoma. 
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